Navigation Links
Free Manicures & Martinis Hits San Francisco and Laguna Niguel
Date:6/2/2009

The American Fertility Association's Infertility Prevention Program

NEW YORK, June 2 /PRNewswire/ -- 7.3 million!

That's how many American women have difficulty conceiving, but many of those cases could have been prevented with some simple lifestyle choices and changes. Education is the key and what better way to learn than over complimentary manicures and martinis?

"Dealing with infertility robs women of control over their own lives. Education about our bodies and about things we can do now to preserve our fertility potential gives that control back. The AFA's Manicures & Martinis Infertility Prevention Program has proven to be an empowering and liberating experience for women, whether they choose motherhood or not," says Corey Whelan, The AFA's Program Director and creator of the growingly popular and impactful Manicures & Martinis series.

The American Fertility Association's Manicures & Martinis Infertility Prevention Program is a national series of events dedicated to young women who are not quite ready to conceive, but might one day want to have a child. Fertility experts will lead conversations about how to prevent infertility whenever possible, the reality of the "biological clock," the harmful effects of STD's and environmental toxins, and the differences between gynecologists and reproductive endocrinologists. Attendees will enjoy complimentary manicures and martinis, or a "Fertiltini" - an all-organic, alcohol-free cocktail.

The AFA's Executive Director, Ken Mosesian, says, "Through post-event surveys, young women are telling us how much they have learned about the basics of reproduction, especially about their biological clocks, about the importance of preventing STD's, and about birth control. One participant said, 'Finally, some answers.'"

The list of cities in which Manicures & Martinis will be held continues to grow, with
'/>"/>

SOURCE The American Fertility Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Free Manicures & Martinis Hits Chicago and Denver
2. Purple: The Hottest Color for Fall in Shoes, Handbags and Martinis
3. The Year of Affordable Healthcare Brings Together San Francisco Community Groups to Tackle Healthcare Crisis
4. MultiVu Video Feed: REESE WITHERSPOON JOINS AVON FOUNDATION FOR WOMEN AND SAN FRANCISCO GENERAL HOSPITAL TO CELEBRATE 5TH ANNIVERSARY OF AVON COMPREHENSIVE BREAST CENTER
5. Video: Reese Witherspoon Joins Avon Foundation for Women and San Francisco General Hospital to Celebrate 5th Anniversary of Avon Comprehensive Breast Center
6. World Renowned San Francisco Chiropractor Dr. Eben Davis to Offer Free Corporate Health Talks
7. San Francisco Bay Area Affiliate of Susan G. Komen for the Cure(R) Applauds Introduction of Bipartisan Cancer Alert Act
8. Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco
9. Nations Largest Home Care Provider Welcomes New Management Team to San Francisco Office
10. The Quantum Group to Present at the 2009 RedChip Investor Conference and Health Tech Forum in San Francisco
11. Project Runway Designer in San Francisco to Educate About Living with HIV and Combat Stigma Associated with the Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 1ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 2ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 3ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 4Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 1Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 3Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 1Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 2Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 3
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 2Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 3Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 5Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 6Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 7Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 8Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 9